Clinical Trial Update: Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document notes a Phase 1 clinical trial evaluating the combination of icotinib and gemcitabine as first-line therapy for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN